Human cadaver multipotent stromal/stem cells isolated from arteries stored in liquid nitrogen for 5 years by Sabrina Valente et al.
Valente et al. Stem Cell Research & Therapy 2014, 5:8
http://stemcellres.com/content/5/1/8RESEARCH Open AccessHuman cadaver multipotent stromal/stem cells
isolated from arteries stored in liquid nitrogen for
5 years
Sabrina Valente1, Francesco Alviano2*, Carmen Ciavarella1, Marina Buzzi3, Francesca Ricci3, Pier Luigi Tazzari3,
Pasqualepaolo Pagliaro3 and Gianandrea Pasquinelli1Abstract
Introduction: Regenerative medicine challenges researchers to find noncontroversial, safe and abundant stem cell
sources. In this context, harvesting from asystolic donors could represent an innovative and unlimited reservoir of
different stem cells. In this study, cadaveric vascular tissues were established as an alternative source of human
cadaver mesenchymal stromal/stem cells (hC-MSCs). We reported the successful cell isolation from postmortem
arterial segments stored in a tissue-banking facility for at least 5 years.
Methods: After thawing, hC-MSCs were isolated with a high efficiency (12 × 106) and characterized with flow
cytometry, immunofluorescence, molecular and ultrastructural approaches.
Results: In early passages, hC-MSCs were clonogenic, highly proliferative and expressed mesenchymal (CD44, CD73,
CD90, CD105, HLA-G), stemness (Stro-1, Oct-4, Notch-1), pericyte (CD146, PDGFR-β, NG2) and neuronal (Nestin)
markers; hematopoietic and vascular markers were negative. These cells had colony and spheroid-forming abilities,
multipotency for their potential to differentiate in multiple mesengenic lineages and immunosuppressive activity to
counteract proliferation of phytohemagglutinin-stimulated blood mononuclear cells.
Conclusions: The efficient procurement of stem cells from cadaveric sources, as postmortem vascular tissues,
demonstrates that such cells can survive to prolonged ischemic insult, anoxia, freezing and dehydration injuries,
thus paving the way for a scientific revolution where cadaver stromal/stem cells could effectively treat patients
demanding cell therapies.Introduction
Regenerative medicine is a group of biomedical ap-
proaches based on cell therapies to solve the problem of
the shortage of organ donors. For many diseases, stem
cell therapy remains a possible alternative but requires a
huge number of cells.
Human mesenchymal stromal/stem cells (hMSCs) are
promising candidates for cell transplantation due to their
ability for self-renewal, with a high growth rate, and their
differentiation potential to produce mesodermal cell types
such as adipocytes, osteocytes and chondrocytes [1]. Al-
though human bone marrow is the best known source of* Correspondence: francesco.alviano@unibo.it
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stated.hMSCs, the harvest is relatively invasive and stem cell
numbers decrease significantly with donor age [2,3]. The
search for an easily accessible source of hMSCs has led
various research groups to explore numerous tissues, in-
cluding arteries [4,5]. However, even if preferred for obvi-
ous ethical reasons, adult tissues can be limited in stem
cell number when obtained from a living donor and thus
the supply is also severely limited [6,7]. Research into an
ideal hMSC source beside living donors is thus a true pos-
sibility that needs to be explored.
Cadaveric multiorgan donors are usually utilized to pro-
vide organ and tissue for transplants, but it is also reason-
able to think that the same donors could represent an
innovative and unlimited reservoir of different types of
stem cells. Emerging evidence supported the idea that vi-
able hMSCs can be isolated and expanded from cadaveric
donors after postmortem intervals exceeding days [8-11].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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from cadavers are also considered an encouraging source for
potential cell-based therapies offering new hope of life after
death [12]. The vascular wall has been described as a possible
niche of vascular stem cells [4] but until now cadaveric vessels
derived from nonheart-beating donors remain unstudied.
Postmortem human allografts are usually used in bypass
surgery and peripheral vascular reconstruction in patients
without sufficient autologous graft material [13]. In these
cases, human vascular segments are cryopreserved for a
long time in tissue-banking facilities to preserve functional
characteristics and to guarantee a continuous availability
of various-caliber segments for clinical application [14].
Due to the availability of adequate prosthetic material rap-
idly boosted in vascular surgery, many segments lie un-
used for years and unfortunately all of these potential
stem cells sources are usually wasted.
In previous studies, we reported that fresh human vas-
cular wall, harvested from heart-beating multiorgan do-
nors, contains vascular stromal/stem cell progenitors that,
in vitro, showed a high differentiation potential [4,5].
In this study, we demonstrate the successful isolation,
propagation and morphological, phenotypic and functional
characterization of human cadaver mesenchymal stromal/
stem cells cells (hC-MSCs) derived by postmortem of vari-
ously sized arterial segments after 4 days from death of the
donor and cryopreservation for more than 5 years.
Materials and methods
Cadaveric variously sized arteries
Donor tissues from Emilia Romagna Cardiovascular Tissue
Bank facilities were used according to the policy approved by
the local ethics committee (University-Hospital St. Orsola –
Malpighi, Bologna, Italy; ethic project number APP-13-01)
and informed consent was obtained from each donor before
specimen collection. Human vascular tissues were explanted
by the cardiovascular team from three young and healthy
multi-tissue donors (nonheart-beating) 12 hours after death.
After collection, the arteries were kept in a sterile box
with Celsior media (IMTIX SANGSTAT, Lyon, France),
a flushing and cold storage solution for solid organ pres-
ervation, and were transferred to the Cardiovascular
Tissue Bank at Bologna University-Hospital St. Orsola –
Malpighi in isothermal boxes filled with ice within 4
hours after procurement. The artery segments were
prepared, classified and transferred in an antibiotic mix-
ture solution with RPMI 1640 (Cambrex Bio Science
Vierviers, Vierviers, Belgium) for 72 hours at +4°C. Four
days after donor death, the arteries were transferred into
sterile bags containing 100 ml fresh cryoprotectant solu-
tion (RPMI 1640 with human albumin; Kedrion, Lucca,
Italy) and Me2SO at a final concentration of 10%. The solu-
tion was cooled at 4°C for 30 minutes before its use. The
bags were kept at 4°C for 30 minutes to allow the Me2SO topenetrate into the tissues completely. The bags were labeled
and cryopreserved in liquid nitrogen vapor in a controlled
rate freezing system (IceCube 1860; Sy-Lab, Wien, Austria)
using an electronically monitored program that allows one
to decrease the temperature at 1°C/minute to −45°C and at
a faster rate thereafter until −120°C has been achieved. The
cryopreserved arterial homografts were stored in the vapor
phase of liquid nitrogen for 5 years. All donors were
screened for virus markers. All procedures were performed
in sterile conditions under a laminar flow cabinet [15].
Isolation and cell culture
Segments of variously sized arteries with different em-
bryological origin (epiaortic district and thoracic aorta)
were obtained by postmortem human donors. The sam-
ples frozen for more than 5 years were dissociated by
enzymic digestion with 0.3 mg/ml Liberase type II
(Roche, Milan, Italy) in serum-free Dulbecco’s modified
Eagle’s medium (DMEM; Lonza, Basel, Switzerland)
overnight at 37°C using a rotor apparatus. After diges-
tion, the homogenate was filtered through a cell strainer
(Becton Dickinson, Franklin Lakes, NJ, USA), seeded at 1 ×
105/cm2 on collagen-I coated T75 flasks plates with smooth
muscle growth medium-2 (Sm-GM2; Lonza) and incubated
at 37°C in a humidified atmosphere with 5% CO2. Non-
adherent cells were removed after 72 hours by washing
with phosphate-buffered saline (PBS). Culture media
was changed every 3 days until testing. When cells were
near confluence, they were expanded in vitro for at
least 14 passages. Before the isolation, a small piece of
each vascular segment as well as the remaining digested
tissue was fixed, hematoxylin and eosin stained and an-
alyzed to verify the efficiency of the isolation method.
Growth kinetics
All fresh isolated hC-MSCs were plated and then cul-
tured until subconfluence. At each passage, viable cells
were enumerated by trypan blue exclusion for evaluation
of growth kinetics. The assessment of cell proliferation
was performed for 3 weeks.
Immunophenotyping
Flow cytometry
The hC-MSC immunophenotype was analyzed for the sin-
gle expression of characteristic markers generally used to
identify the hMSCs and stem cells using a flow cytometry
analysis. To detect surface antigen, cells taken at passage 3
were washed twice with PBS and incubated for 20 minutes
using the following extensive conjugated antibodies panel:
anti-CD44-fluorescein isothiocyanate (FITC), anti-CD73-
phycoerythrin (PE), anti-CD90-phycoerythrin-cyanine
5, anti-CD105-PE, anti-CD14-FITC, anti-CD31-PE,
anti-CD34-FITC, anti-CD45-allophycocyanin, von Willeb-
rand Factor (vWF; Dako Cytomation, Glostrup, Denmark),
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rβ (R&D Systems, Inc., Minneapolis, MN, USA), anti-NG2
(R&D Systems), anti-STRO-1 (R&D Systems), anti-Oct-4
(Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-
Notch-1 (Santa Cruz Biotechnology) and HLA-G-FITC
(Abcam, Cambridge, UK). The following secondary mono-
clonal antibodies (mAbs) were used after cell staining with
unlabeled primary mAbs: anti-mouse IgG-allophycocyanin
(Beckman-Coulter, Fullerton, CA, USA), anti-rabbit IgG-
FITC (Dako, Glostrup, Denmark). To reveal vWF and Oct-
4, the cells were fixed, permeabilized with the IntraPep Kit
(Beckman-Coulter) and subsequently incubated with
anti-mouse IgG-FITC (Dako). To study coexpression of
CD73 and CD105 on CD34/CD45-negative hC-MSCs,
cells were simultaneously incubated respectively with
CD34-FITC, CD45-allophycocyanin, CD73-PE mAbs and
CD34-FITC, CD45-allophycocyanin, CD105-PE mAbs. In
addition, to verify the percentage of CD44+/CD90+ simul-
taneously expressing CD146 and PDGF-rβ, triple staining
analyses were performed respectively with CD44-FITC,
CD90-phycoerythrin-cyanine 5, PDGF-rβ conjugated
with anti-mouse IgG-allophycocyanin and CD44-FITC,
CD90-phycoerythrin-cyanine 5, CD146-PE mAbs. Nega-
tive controls were performed using appropriate conju-
gated irrelevant antibodies. Samples were analyzed using a
Navios FC equipped with two lasers for data acquisition
(Beckman-Coulter). Results were analyzed were elabo-
rated with Kaluza FC Analysis software (Beckman-
Coulter).
Immunofluorescence analysis
To detect intracytoplasmic antigens, an immunofluores-
cence staining was performed. Briefly, 4 × 104 hC-MSCs
were cultured on collagen biocoated slide chambers (BD
Bioscence, San Jose, CA, USA) until near confluence. Sub-
sequently, the samples were washed with PBS, followed by
2% paraformaldehyde plus 0.1% Triton X-100 for 4 mi-
nutes at room temperature. Fixed cells were then blocked
in 1% bovine serum albumin in PBS solution for 30 mi-
nutes at room temperature and labeled for 1 hour at 37°C
with primary antibodies. After repeated washing, the slides
were incubated with Alexa Fluor 488 (1:250; Invitrogen,
Carlsbad, CA, USA) secondary antibodies in 1% bovine
serum albumin in PBS for 1 hour at 37°C in the dark. Fi-
nally, after several rinses, the samples were mounted and
nuclei counterstained with Pro Long anti-fade reagent
with DAPI (Molecular Probes, Milan, Italy). Primary anti-
bodies and dilutions were used as follows: α-smooth
muscle actin (1:9,000, Sigma, Saint Louis, Missouri, USA),
calponin (1:40; Dako Cytomation), H-caldesmon (1:75;
Dako), Desmin (1:300; Dako), Vimentin (1:100; Dako) and
ki-67 (1:100; Novocastra, Wetzlar, Germany). In addition,
the following neuronal markers were investigated: Neuron
Specific Enolase (1:12,000; BioGenx, Fremont, CA, USA),Nestin (1:400; Millipore, Billerica, MA, USA), Neurofila-
ment (1:100; Dako) and S100 (1:200; Dako). For a negative
control, the samples were processed omitting the primary
antibody, and no signal was detected. Images were taken
on a Leica DMI4000 B inverted fluorescence microscope
(Leica Microsystems, Milan, Italy) at × 20 magnification.
Reverse transcriptase polymerase chain reaction gene
expression analysis
Total RNA was extracted from hC-MSCs grown as an ad-
herent monolayer and in suspension as spheres using RNA-
extracting TRIreagent according to the manufacturer’s in-
structions (TRIzol reagent; Invitrogen). One microgram of
total RNA was reverse transcribed in a 20 μl volume of re-
action using a High Capacity Reverse Transcription Kit
(Applied Biosystems, Carlsbad, CA, USA). All polymerase
chain reaction (PCR) products were analyzed on 2% agarose
gel electrophoresis with Tris-acetate–ethylenediamine tet-
raacetic acid buffer 1×, stained with ethidium bromide
incorporation and photographed under ultraviolet light. β-
Microglobulin was used as the housekeeping gene. A 100
base pair (bp) DNA ladder was loaded to allow PCR
product size identification. The gel was subjected to
electrophoresis at a constant 100 V for 45 minutes.
Genes and respective primers are presented in Table 1.
The PCR primers were purchased from Invitrogen. β2-
Microglobulin was used as the housekeeping gene to
value the cDNA quality.
In vitro spheroid formation
To determinate whether hC-MSCs have the ability to
grow forming spheres in nonadherent conditions, cells
taken at passage 3 were filtered through a cell strainer to
obtain a single cell suspension and plated at density of
3 × 104 cells/well in ultralow attachment 24-well plates.
After few days, cell aggregation in spheroids was ob-
served under light microscopy (LM) and processed for
gene expression analysis as described previously.
Clonogenic assay
To assess the self-renewal capacity, passage 3 hC-MSCs
were trypsinized, counted and plated in 96-well plates at
a limiting dilution of 0.3 cells/100 μl concentration to
have a single clone per well. During the culture, each
well was daily examined for colony formation and
photographed under LM at × 4 magnification. Each test
was performed in triplicate. After 1 month, confluent
wells were counted to determine the number of pro-
duced colonies.
Multilineage differentiation potential
hC-MSCs taken at passage 3 were differentiated towards
mesodermal lineages: adipogenesis, osteogenesis, chon-
drogenesis, leiomyogenesis and angiogenesis.
Table 1 Reverse transcriptase polymerase chain reaction: primers and conditions
Gene Primer sequence Amplicon length (base pairs) T (°C)
β-Microglobulin Reverse: 5′-ATCTTCAAACCTCCATGATG-3′ 114 58
Forward: 5′-ACCCCCACTGAAAAAGATGA-3′
SOX2 Reverse: 5′-GCGCCGCGGCCGGTATTTAT-3′ 208 61
Forward: 5′-CCGGCGGCAACCAGAAGAACAG-3′
c-KIT Reverse: 5′-CATACAAGGAGCGGTCAACA-3′ 275 67
Forward: 5′-GTCTCCACCATCCATCCATC-3′
OCT-4 Reverse: 5′-CCACATCGGCCTGTGTATAT-3′ 380 62
Forward a: 5′-CTCCTGGAGGGCCAGGAATC-3′ 402
Forward b: 5′-ATGCATGAGTCAGTGAACAG-3′
NOTCH-1 Reverse: 5′-TGGCATCAGCTGGCACTCGTCC-3′ 496 67
Forward: 5′-CCGGCTGGTCAGGGAAATCGTG-3′
KDR Reverse: 5′-TTTGTCACTGAGACAGCTTGG-3′ 555 61
Forward: 5′-TATAGATGGTGTAACCCGGA-3′
PPAR-γ Reverse: 5′-ACAGTGTATGAGTGAAGGAAT-3′ 101 54.5
Forward: 5′-CAGTGTGAATTACAGCAAACC-3′
Osteocalcin Reverse: 5′-TCAGCCAACTCGTCACAGTC-3′ 175 58
Forward: 5′-GTGCAGAGTCCAGCAAAGGT-3′
Osteopontin Reverse: 5′-GTCATGGCTTTCGTTGGACT-3′ 200 58
Forward: 5′-TTGCAGTGATTTGCTTTTGC-3′
RUNX2 Reverse: 5′-GACTGGCGGGGTGTAAGTAA-3′ 161 58
Forward: 5′-TCTGGCCTTCCACTCTCAGT-3′
Type II collagen Reverse: 5′-GGGGGTCCAGGGTTGCCATTG-3′ 352 58
Forward: 5′-ACGGCGAGAAGGGAGAAGTTG-3′
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Adipogenesis was induced by plating hC-MSCs at dens-
ity of 6 × 104 cells/well in a 24-well plate using the Mes-
enchymal Stem Cell Adipogenesis Kit (Chemicon
International, Temecula, CA, USA) according to the
manufacturer’s instructions. Induction medium was re-
placed every 2 to 3 days for 2 to 3 weeks and alternated
with maintenance medium (DMEM 10% fetal bovine
serum (FBS) and 0.02 mg/ml insulin). Three complete
cycles of induction/maintenance medium stimulated op-
timal adipogenic differentiation, forming adipocytes.
Control cells were culture in basal medium (DMEM plus
10% FBS). To confirm their identity, hC-MSCs were
fixed and the cytoplasmic presence of lipid droplets was
assessed by Oil Red O staining and transmission elec-
tron microscopy (TEM). The cells cultured were also
processed for reverse transcriptase (RT)-PCR analysis as
specified above to investigate the expression of adipo-
genic transcription factor peroxisome proliferator-
activated receptor gamma (PPARγ).
Osteogenic potential
Osteogenesis was induced by plating hC-MSCs at dens-
ity 6 × 104 cells/well in a 24-well plate using theosteogenic induction medium Mesenchymal Stem Cell
Osteogenesis Kit (Chemicon International) with the
addition of 10% FBS, maintained for 3 weeks, replacing
the medium every 2 to 3 days, according to the manu-
facturer’s instructions. Control cells were cultured in
basal medium (DMEM plus 10% FBS). All experiments
were followed by morphological evaluation by LM. To
detect mineral deposition, the cells were fixed and
assessed by Alizarin Red staining and TEM investiga-
tion. The cells cultured were also processed for RT-
PCR analysis as specified above to investigate the
expression of osteogenic markers Osteocalcin, Osteo-
pontin and RUNX-2.
Chondrogenic potential
Aliquots of 2.5 × 105 cells were pelleted in polypropylene
conical tubes in differentiation basal medium chondro-
genic (Poietics, Lonza) supplemented with hMSC Chon-
drogenic Single Quotes (Poietics, Lonza) and 10 ng/ml
transforming growth factor beta-3 (SIGMA, Lonza). This
medium was replaced every 2 to 3 days for 3 weeks.
Control cells were cultured in the same differentiation
medium without transforming growth factor beta-3. Pel-
lets were formalin fixed, paraffin embedded and stained
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Immunostaining for type II collagen (1:200; Chemicon
Millipore, Billerica, MA, USA) using a nonbiotin-
amplified method (NovoLink Polymer Detection Kit;
Novocastra, Newcastle upon Tyne, UK) was performed
according to manufacturer’s instructions. Images were
acquired using Image-Pro PlusW 6 software (v. 4.5 [16];
MediaCybernetics, Rockville, MD, USA) at × 20 magnifi-
cation. All samples were also analyzed by TEM to evalu-
ate proteoglycan synthesis. To investigate the expression
of chondrogenic marker type II collagen, 10 consecutive
10-μm-thick sections from the same samples used for
the chondrogenic assays were processed for RT-PCR
using the RNeasy® Formalin-Fixed, Paraffin-Embedded
kit (Qiagen, Valencia, CA, USA) according to the manu-
facturer’s instructions.
Smooth muscle cell differentiation
Cells (15 × 103 cells/well) were seeded in a six-well
plate in SmGM-2. After 24 hours, the medium was
changed for induction medium containing SmGM-2 plus
10 ng/ml transforming growth factor beta-1 and 5 ng/ml
PDGF-BB (all growth factors from Sigma). The medium
was changed every 3 days and the induction period
lasted for 7 days. Control cells were cultured in SmGM-
2 without additional growth factors. At the end of differ-
entiation, hC-MSCs were fixed and resin embedded for
TEM analysis to disclose contractile filaments induction
and organization.
Angiogenic potential
The ability to form capillary-like tubes was tested in a
semisolid matrix. Briefly, hC-MSCs taken at passage 3
were cultured at confluence for 7 days in DMEM plus
2% FBS with 50 ng/ml vascular endothelial growth factor
(VEGF; Sigma). Control cells were culture in basal
medium (DMEM plus 10% FBS). At the end of induc-
tion, 5 × 103 hC-MSCs were plated onto the Matrigel
(BD Bioscence) solution, solidified and incubated at
37°C 5% CO2. Human umbilical vein endothelial cells
were used as a positive control. The formation of capillary-
like structures was observed using LM after 2, 4 and 6
hours. In parallel experiments, the induced and control
hC-MSCs were analyzed at flow cytometry for the ex-
pression of vWF and CD31 endothelial markers.
Transmission electron microscopy
For TEM, pellets of uninduced and induced hC-MSCs
were washed with phosphate buffer, fixed for 24 hours at
4°C in Karnowsky fixative (2% glutaraldehyde, 4% formal-
dehyde in 0.1 M phosphate buffer), post-fixed in 1% buff-
ered osmium tetroxide for 1 hour at room temperature,
dehydrated through graded ethanol, followed by propylene
oxide, and embedded in Araldite resin. Ultrathin sectionswere transferred to specimen support grids and were
counterstained with uranyl acetate and lead citrate prior
to examination in a Philips 400 T transmission electron
microscope (FEI Company, Milan, Italy).
Immunomodulatory assay
To test the immunomodulatory activity, hC-MSCs
at passage 3 were trypsinized and plated at a density of
25 × 103 cells/cm2 in a six-well plate (n = 3). They were
then cocultured with peripheral blood mononuclear
cells (PBMCs), derived from healthy volunteer donors of
the Transfusion Medicine Service, Bologna University-
Hospital St. Orsola – Malpighi (according to the policy
of the local ethical committee). PBMCs were isolated by
density gradient centrifugation and plated on the hC-
MSC monolayer at a density of 2.5 × 106 cells/well in
RPMI 1640 (Lonza, Walkersville, MD, USA). PBMCs
were activated by addition of phytohemagglutin (PHA,
5 g/ml; Sigma-Aldrich, Saint Louis, Missouri, USA) and
incubated for 72 hours at 37°C, 5% CO2. PBMCs were
fixed with 70% ethanol at 4°C, stained with propidium
iodide (Beckman Coulter) at room temperature for 10
minutes and analyzed by flow cytometry.
Statistical analysis
The results are presented as the mean (from the indi-
cated number of samples) ± standard deviation. Two-
tailed t tests were conducted to determine statistical
significance.
Results
Human cadaver mesenchymal stromal/stem cell isolation,
early characterization and expansion
hC-MSCs were successfully isolated and expanded
in vitro from three human cadaver arterial allografts
after 4 days postmortem and more than 5 years of liquid
nitrogen bank storage. After cell recovery, histological
observation of the residual arterial tissue revealed that
the tissue architecture and tunica layering were no lon-
ger distinguishable while only rare cells still remained
enclosed in the native tissue (Figure 1A, B). The initial
cell number recovered was overall 4 × 105 cells/cm2.
These results documented the good efficiency of the iso-
lation procedure. In early passages (<3), these cells,
showing strong plastic adhesion, formed small colonies
that rapidly became confluent, giving origin to a vorti-
cous and intersecting pattern suggesting an innate clo-
nogenic ability (Figure 1C, D); numerous poly-nucleated
cells (one out of 20 cells each 100× microscopic field)
with two, three or more nuclei were also evident; most
of the adherent cells had a spindle-shaped appearance;
dendritic and rounded cells were also seen (Figure 1E).
hC-MSCs were long-lived in culture, highly proliferating
and exhibited evidence of ongoing cell division. We
Figure 1 Human cadaver mesenchymal stromal/stem cell isolation, early characterization and expansion. Representative histological
staining of native (A) and digested arterial tissue (B) after enzymatic isolation of human cadaver mesenchymal stromal/stem cells (hC-MSCs)
(scale bars =10 μm). (C), (D) After harvesting, hC-MSCs collected from three postmortem artery segments show clonogenic activity (scale
bars = 50 μm). (E) Numerous poly-nucleated cells (arrow), spindle-shaped cells, dendritic (arrowhead) cells and rounded cells (scale bar = 20 μm).
(F) hC-MSC growth kinetics. After 3 weeks of culture, the cells seeded were expanded approximately 20-fold and yielded 250 × 106 cells. (G) ki-67
nuclear immunoreactivity (scale bar = 75 μm). (H) The hC-MSCs at passage 3 became elongated and spindle-shaped with long and thin
cytoplasmic projections (scale bar =10 μm).
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their proliferative capacity. The cell proliferation rate of
hC-MSCs was determined by evaluating the total num-
ber of hC-MSCs at initial seeding and after 3 weeks
of subconfluent culture condition; the total cell count
was performed with a hemocytometer and trypan blue
exclusion. As shown in Figure 1F, 12 × 106 freshly de-
rived hC-MSCs were expanded approximately 20-fold
in 3 weeks and yielded 250 × 106 cells. The ki-67 nuclear
immunoreactivity demonstrated that more than 90%
of the overall seeded cells were cycling (Figure 1G).
After the passage 3, the starry-like appearance of cell
culture became lost and more classic growth pattern
was seen; hC-MSCs were elongated and homogeneously
spindle-shaped in morphology with thin cytoplasmic
projections (Figure 1H).
Human cadaver mesenchymal stromal/stem cell
phenotypic and molecular characterization
At the third replaying, flow cytometry analysis showed
that hC-MSCs expressed recognized markers of hMSCs
(CD44, CD73, CD90 and CD105), pericyte antigens
(CD146, PDGF-rβ and NG2) and stemness markers
(Stro-1, Oct-4 and Notch-1). On the contrary, no cellsexpressed markers of hematopoietic lineage (CD14 and
CD45), hematopoietic progenitor (CD34) or endothelial
cells (CD31, vWF). The isolated cells also constituting
expressed of HLA-G antigen, a well-known tolerogenic
molecule involved in the immuomodulatory activity of
mesenchymal stromal/stem cells [17] (Figure 2A). Triple
flow cytometry immunostaining of hC-MSCs revealed
that 98.6% of CD34–/CD45– were CD73+ and 100% of
CD34–/CD45– were CD105+. Regarding pericyte anti-
gens, 99.4% of CD44+/CD90+ coexpressed PDGF-rβ and
74% of CD44+/CD90+ stained with CD146 (Figure 2B).
In addition to flow cytometry analysis, a single immuno-
fluorescence staining was performed to investigate the
smooth muscle (α-smooth muscle actin, calponin, h-
caldesmon, Vimentin and Desmin) and neural (NSE,
Nestin, Neurofilament and S100) phenotypes. The inter-
mediate filaments Vimentin and Nestin were strongly
expressed virtually in all cells (Figure 2C, D), whereas
Neurofilament was positive in rare cells. The remaining
markers were negative. Gene expression analysis per-
formed at passage 3 revealed that hC-MSCs constitu-
tively expressed high transcripts associated with similar
stemness status as SOX2, c-KIT, the two isoforms of
OCT-4 (380 bp, 308 bp) and KDR, while NOTCH-1
Figure 2 Human cadaver mesenchymal stromal/stem cell phenotypic and molecular characterization. (A) Representative flow cytometry
analysis of mesenchymal, pericytic, stem cell, hematopoietic and vascular markers. Isotype controls are presented as filled black histograms, the
specific cell markers as white histograms. (B) Flow cytometry analysis of hematopoietic, mesenchymal and pericyte marker coexpressions.
Percentage and cytograms from a representative experiment. Immunofluorescence staining for Vimentin (C) and Nestin (D) in human cadaver
mesenchymal stromal/stem cells (hC-MSCs). Nuclei were counterstained with DAPI (blue) and cell positive in green. Scale bars = 100 μm. (E) Stem
cell gene expression analysis of SOX2, c-KIT, OCT-4, NOTCH-1 and KDR. β-Microglobulin was used as the housekeeping gene. The far left lane
contains a 100 base pair ladder.
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are expressed in embryonic stem cells and are involved in
survival and proliferation/differentiation pathways.
Human cadaver mesenchymal stromal/stem cell stemness
properties
hC-MSCs showed a prominent clonogenic capacity; after
seeding, one seeded cell was observed in numerous wells
and was followed during all culture periods (Figure 3A).
Ten days later, a sporadic group of eight to 10 cells ap-
peared in about 3% of the seeded wells; at day 30, a rele-
vant increase of wells (about 8% of the total seededwells) displayed clonogenic growth (Figure 3B). Interest-
ingly, sporadic single cell clones showed no clonogenic
potential and exhibited a ring-shaped morphology gener-
ated by the extrusion of long and thin cell processes that
bent, forming circular profiles (Figure 3C).
hC-MSCs also showed the ability to form spheroids
when grown in nonadherent conditions; after 5 days
of culture they generated multiple spheroids that resem-
bled embryo-like bodies when observed in plate using
an inverted LM (Figure 3D). Molecular analysis by RT-
PCR showed expression of SOX2, OCT-4, c-KIT and
KDR (Figure 3E).
Figure 3 Human cadaver mesenchymal stromal/stem cell stemness property. Clone-forming potential of (A) a single seeded human
cadaver mesenchymal stromal/stem cell (hC-MSC) (arrow) that (B) reached the confluence after 30 days of culture (scale bars = 50 μm). (C)
Nonclonogenic single cell with a ring-shaped morphology (scale bar = 10 μm). (D) When plated in nonadhesion conditions, free floating spheres
are generated (scale bar = 50 μm). (E) Reverse transcriptase polymerase chain reaction analysis performed on spheroids showed expression of
SOX2, OCT-4, c-KIT and KDR. β-Microglobulin was used as the housekeeping gene. The far left lane contains a 100 base pair ladder.
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mesengenic potential
hC-MSCs were cultured in appropriate culture condi-
tions to test their tripotential commitments including
adipogenic and osteo-chondrogenic lineages. Leiomyo-
genic and angiogenic potentials were also explored.
Adipogenic differentiation was successful and con-
firmed by Oil Red O staining and ultrastructural ana-
lysis. hC-MSCs showed multiple lipid-rich vacuoles in
the cytoplasm that increased in size and number with
the time of induction and were intensely stained red
(Figure 4B). TEM revealed confluent lipid droplets,
small dense mitochondria and intense endocytic activity
(Figure 4C). RT-PCR showed the upregulation of PPARγ,
a critical player of adipocyte differentiation (Figure 4D).
Osteogenic differentiation was confirmed by Alizarin
Red staining and ultrastructure. The differentiation was
noted as early around 10 days of induction by morpho-
logical changes and, at the end of the induction period,
by calcium accumulation (Figure 4F). TEM revealed in
the extracellular space moderately to electron dense fi-
brillary deposits that were decorated with needle-shaped
hydroxyapatite crystals (Figure 4G). RT-PCR showed
that Osteocalcin, Osteopontin and RUNX-2 increased
transcript expression (Figure 4H). All genes investigated
are expressed in osteogenic differentiation pathways.
Chondrogenic differentiation was documented using
Alcian Blue dye, human collagen type II immunostaining
and ultrastructure. During the induction, matrix changesin micromass cell culture were noted and, at the end of
the induction period, alcianophilia in proteoglycan-rich
extracellular matrix was seen (Figure 4J). Changes in the
extracellular matrix were accompanied by the presence
of clear vacuoles in the cell cytoplasm that PAS staining
with and without diastase pretreatment showed to be
glycogen inclusions (Figure 4K). Immunohistochemistry
analysis revealed, in the extracellular matrix, the diffuse
presence of human type II collagen (Figure 4L), a spe-
cific marker for chondroblasts, which is typically found
in joint cartilage. Ultrastructural analysis performed at
the periphery of the cell micromass showed proteogly-
can particles adherent to the cell membrane (Figure 4M).
RT-PCR showed type II collagen mRNA expression
(Figure 4N). Leiomyogenic differentiation was analyzed
by TEM. At the end of induction, ultrastructural features
were peripherally arranged contractile filaments with
subplasmalemmal linear densities and dense bodies,
glycogen deposits and profiles of rough endoplasmic
reticulum; in the extracellular matrix, elastic lamellae
were seen (Figure 4P, Q). All mesodermal commitment
controls retained their morphology and did not display
cytoplasm lipid vacuoles (Figure 4A), calcium deposition
in the extracellular matrix (Figure 4E), proteoglycan-rich
extracellular matrix (Figure 4I) and contractile filaments
(Figure 4O).
Angiogenic differentiation was evaluated using a
semisolid matrix assay. After 6 hours, the uninduced
hC-MSCs organized themselves into a few capillary
Figure 4 (See legend on next page.)
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Figure 4 Human cadaver mesenchymal stromal/stem cell mesengenic potential. (A) Control human cadaver mesenchymal stromal/stem
cells (hC-MSCs) did not display cytoplasm lipid drops. (B) Oil Red O stained adipocytic multivacuolar cells in red. (A), (B) Scale bars = 10 μm.
(C) Transmission electron microscopy (TEM) showed multiple lipid vacuoles and small dense mitochondria in the cytoplasm. L, lipid droplets; M,
mitochondria. Scale bar = 2 μm. (D) Reverse transcriptase polymerase chain reaction of peroxisome proliferator-activated receptor gamma (PPARγ)
expression. β-Microglobulin was used as the housekeeping gene. (E) Control hC-MSCs did not display calcium deposition in the extracellular
matrix. (F) Alizarin Red stained calcium deposits. (E), (F) Scale bars = 10 μm. (G) TEM confirmed the presence of osteoid matrix and needle-shaped
hydroxyapatite crystals (arrow). Scale bar = 2 μm. (H) Gene expression analysis of Osteocalcin, Osteopontin and RUNX-2. β-Microglobulin was used
as the housekeeping gene. (I) Control hC-MSCs did not display proteoglycan-rich extracellular matrix. (J) Alcian Blue stained proteoglycan-rich
extracellular matrix. (K) Glycogen inclusions (arrow) stained by PAS staining with and without diastase pretreatment. (I), (J), (K) Scale bars = 10 μm.
(L) Human collagen type II immunostaining positive in the extracellular matrix. Scale bar = 100 μm. (M) TEM analysis revealed proteoglycans
adherent to the cell membrane (arrows). Scale bar = 2 μm. (N) Molecular analysis of type II collagen transcript expression. β-Microglobulin was
used as the housekeeping gene. (O) Control hC-MSCs did not display contractile filaments. (P) TEM analysis revealed peripherally arranged
contractile filaments, dense bodies, glycogen deposits (*) and profiles of rough endoplasmic reticulum. (Q) Elastic lamellae in the extracellular
matrix (arrow). O), (P), (Q) Scale bars = 2 μm. Matrigel assay in the absence (R) and presence (S) of vascular endothelial growth factor (VEGF;
50 ng/ml for 7 days) after 6 hours. (R), (S) Scale bars = 10 μm. (T), (U) Flow cytometry analysis for von Willebrand factor (vWF) and CD31
expression in hC-MSCs cultured in the absence and in the presence of VEGF. Uninduced cells are presented as filled black histograms,
differentiated cells as white histograms.
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in the medium (Figure 4R). When cultivated in the
presence of VEGF, the cells rapidly aligned themselves,
formed hollow tube-like structures with thin cytoplasmic
projections sprouting from the cell periphery and ap-
peared connected by thicker projections forming an
evident capillary-like network (Figure 4S). Flow cytome-
try analysis showed that vWF and CD31, markers of
mature endothelium, were clearly promoted by VEGF
(Figure 4T, U). On the contrary, human umbilical vein
endothelial cells, used as positive control, spontaneously
aggregated in a capillary-like network when seeded on
Matrigel (data not shown).
Human cadaver mesenchymal stromal/stem cell
immunomodulatory ability
To test whether hC-MSCs exert an immunomodulatory
effect on co-cultured PHA-stimulated PBMC prolifera-
tion, the PBMC distribution in the cell cycle phases was
evaluated (Figure 5). In three independent experiments
we observed that unstimulated PBMCs were all in the
G0/G1 phase, while activated PBMCs without hC-MSC
co-culture were 63.8 ± 2.1% in the G0/G1 phase, 16.1 ±
2.9% in the S phase and 12.8 ± 3.9% in the G2 phase.
When hC-MSCs were present in coculture, we observed
a significant increase of PBMCs in the G0/G1 phase
(92 ± 0.5%) and an equally significant reduction of PBMCs
in the S and G2/M phases, respectively 9.1 ± 0.4% and
0.2 ± 0.1%. These results suggested that hC-MSCs have
an immunomodulatory effect on stimulated PBMCs
mediated by cell cycle arrest.
Discussion
The self-renewal and multilineage potential of hMSCs
have generated a growing interest about potential appli-
cation of these cells in tissue regeneration and cell-based
therapies. In addition to bone marrow, various humantissues have also been reported to contain hMSCs cap-
able of multilineage differentiation [5,7,18-21]. However,
hMSCs are extremely rare and available in very low
numbers when recovered by biopsy material [6,7], and
in vitro expansion is required to achieve the necessary
cell number useful for clinical applications [2]. To match
the demand for regenerative medicine it is necessary to
find an available and unlimited reservoir of hMSCs.
Bone marrow transplantation [9] as well as pancreatic is-
lets [22] from cadaveric donors have been reported in
several studies as a clinical reality. Asystolic, cadaver do-
nors are utilized to provide multiple organs and tissues
for transplants, and stem cell retrieval from these
sources could represent an original and noteworthy
choice. Cadaver donors may become intriguing and ad-
vantageous, promising stem cell reservoirs due to re-
stricted ethical issues, availability of tissues and cells;
moreover, written consent procurement and safety col-
lection procedures are extensively implemented. Fur-
thermore, differentiated cells in the cadaver die in a
couple of days, whereas stem cells such as mesenchymal
stromal/stem cells residing in a hypoxic niche can sur-
vive and be harvested even after death. These quiescent
or dormancy stem cells survive by adapting to low oxy-
gen consumption with a slow metabolism and no tran-
scription program [23]. The isolation of viable and
functional cadaveric stem cells from human bone mar-
row [24,25], brain [10,26] and muscle [12] up to many
days postmortem is possible today, but cadaveric cryo-
preserved vessels remain unstudied.
Cadaveric human vessels are usually used as a bypass
in peripheral vascular disease [27]. After clinical suitabil-
ity, human vascular segments are stored at deep subzero
temperatures, allowing preservation of vascular tissues
for a virtually infinite time [28] in banking facilities [29].
With the use of adequate prosthetic materials rapidly
boosted in vascular surgery, many cryopreserved banked
Figure 5 Human cadaver mesenchymal stromal/stem cell immunomodulatory ability. Human cadaver mesenchymal stromal/stem cell
(hC-MSC) immunosuppressive effect on activated peripheral blood mononuclear cells (PBMCs). Analysis of the PBMC distribution in cell cycle
phases after coculture with hC-MSCs. Phytohemagglutin (PHA)-activated PBMCs reduced proliferation when co- = cultured with hC-MSCs. Data
expressed as a percentage of PBMCs for each cell cycle phase. Mean ± standard deviation; n = 3. *P <0.05; ***P <0.001.
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discharge after 5 years of storage; any viable and func-
tional cell is therefore usually wasted. These facts justify
our research on the use of long-time frozen arteries as
an alternative and unlimited source of these cells for
allogenic use.
In this study, cell isolation, expansion, morphological,
phenotypic and functional characterization of hC-MSCs
was carried out successfully from human vascular seg-
ments after 4 days from the death of donor and cryopre-
served for more than 5 years. We showed that hC-MSCs
can persist after prolonged ischemic insult and can sur-
vive for extended postmortem periods and long-time
cryopreservation without losing their stemness features.
We believe that anoxia, the lack of nutrients, cryogenic
stress and tissue dehydration/rehydration, and other
postmortem factors might contribute to selecting only
the more robust and undifferentiated stem cells over the
more differentiated cells from tissues in living donors.
We successful isolated a cell population that displayed
morphological characteristics, immunophenotypic markers
and differentiation similar to hMSCs as defined by the
International Society for Cellular Therapy criteria [1].
Using an enzymatic method, we had a high recovery effi-
ciency; in fact, we isolated an average of 4 × 105 cells/cm2
by 4 cm2 arterial segments and, after 3 weeks of expansion,
250 × 106 cells were achieved. This high output recoverymay guarantee the possibility to isolate a cell amount
needed for clinical application, limiting the necessity
for a prolonged in vitro expansion that could alter stem
cell features. In early passages (<3), the hC-MSCs showed
intensive clonogenic ability, the 12 × 106 freshly derived
hC-MSCs adhered to plastic forming multiple colonies
that rapidly became confluent, and the hC-MSCs were
long-lived in culture and highly proliferative as demon-
strated by their growth kinetics and immunofluorescence
staining for ki-67.
In agreement with International Society for Cellular
Therapy criteria, postmortem derived cells expressed the
surface antigens commonly found in hMSCs – that is,
CD44, CD73, CD90 and CD105 – and the lack of the ex-
pression of hematopoietic (CD14, CD34 and CD45) and
vascular (vWF and CD31) lineages by flow cytometry
confirmed the absence of blood and endothelial commit-
ted cells. Furthermore, triple flow cytometry immuno-
staining evidenced that more than 98.6% of CD34–/
CD45– cells expressed molecules commonly found in
mesenchymal stromal/stem cells such as CD73 and
CD105. Regarding the pericyte phenotype of hC-MSCs,
99.4% and 74% of CD44+/CD90+ coexpressed PDGF-rβ
and CD146. In addition, they also expressed stemness
molecules – that is, Stro-1, Oct-4 and Notch-1 – and
HLA-G antigen, a well-known tolerogenic molecule [17]
involved in the immunomodulatory activity of hMSCs.
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sion of Vimentin and Nestin; rare Neurofilament cells
were positive. Nestin, a type VI intermediate filament,
has been used to identify multipotent neural cells cap-
able of differentiating along several neural lineages [30].
Because of the Nestin positivity and the presence of
dendritic-like cells in inverted LM, we ruled out the pos-
sible contribution of a neural phenotype using additional
neural markers such as NSE and S-100 that were com-
pletely negative. Apart from neural lineages, Nestin has
been found expressed in normal arterial vasa vasorum as
well as in endothelial cells of normal and pathological
angiogenesis [31], and more recently in multipotent vas-
cular stem cells of the rat [32]. Moreover, Nestin expres-
sion in hC-MSCs could be also related to the neural
crest cell embryological origin of epiaortic segments and
the aortic arch. Finally, the cells also expressed pericyte
markers such as CD146, PDGF-rβ and NG2; this finding
supports the evidence that pericytes may represent the
hMSC in situ counterpart [33].
hC-MSCs retained the ability to express a set of genes
associated with the embryonic stem cell marker and in-
volved in the survival and proliferation/differentiation
pathway including SOX2, c-KIT, the two isoforms of
OCT-4 (380 bp, 308 bp) and KDR, while NOTCH-1
mRNA levels were lower. The high expression level of c-
KIT and OCT-4 could be explained by hypothesizing that
a subset of hC-MSCs had more ancestral characteristics.
However, the morphology and immunophenotype are
not exclusive to give a cell population’s property of stem-
ness: thus other features common to stem cells were in-
vestigated. As demonstrated previously [5], using ultralow
attachment plates we selected from the hC-MSC cell
population a stem cell subset that grows in suspension,
forming embryoid body-like structures. Molecular analysis
by RT-PCR showed expression of SOX2, OCT-4, c-KIT
and KDR. One interesting characteristic related to the
more primitive measure of progenitor cell activity is the
ability of cells to reform colonies; accordingly, the clono-
genic potential of single hC-MSCs was assessed at limiting
dilution concentration and 8% of the total seeded wells
displayed clonogenic properties. Nonclonogenic single
cells had a ring-shaped morphology generated by the ex-
trusion of long and thin cell processes that bent, forming
circular profiles.
As other criteria for stem cells, it is generally considered
necessary to demonstrate multipotency differentiating
into adipocytes, osteocytes and chondrocytes. Adipogen-
esis resulted in a progressive increase in the size of mul-
tiple and confluent lipid-rich vacuoles, small dense
mitochondria and intense endocytic activity into the
cytoplasm and upregulation of PPARγ. Osteogenesis re-
sulted in calcium deposition, electron-dense osteoid fi-
brillary matrix, needle-shaped hydroxyapatite crystalsand increased expression of osteogenic differentiation genes
(for example, Osteocalcin, Osteopontin and RUNX-2).
Regarding chondrogenesis, cartilaginous differentiation
was associated with alcianophilic, proteoglycan-rich
extracellular matrix, glycogen accumulation and colla-
gen type II mRNA expression and protein deposition in
the cell cytoplasm.
Moreover, considering the vascular derivation of hC-
MSCs, leiomyogenic and angiogenic abilities were also
explored. The good propensity of hC-MSCs for leiomyo-
genic commitment resulted in the generation of myoid
cells with peripherally arranged contractile filaments,
subplasmalemmal linear densities and dense bodies.
Similar to angiogenesis, VEGF-preconditioned hC-MSCs
showed that these cells appeared connected by thicker
projections forming an evident capillary-like network in
a Matrigel assay. VEGF induction was accompanied by
high expression of vWF and CD31, typical mature endo-
thelium markers, supporting the commitment towards
the endothelial cell lineage.
Apart from the multilineage differentiation ability [34],
hMSCs are also capable of modulating immune re-
sponses, both in vitro and in vivo [35]. Immunomodula-
tory properties were initially reported using bone
marrow-derived cells [36] and subsequently also using
several alternative human sources [37-39]. In our study,
to evaluate the immunomodulatory effects on immune
system mononuclear cell proliferation, hMSCs were
added to a mitogen-stimulated PBMC cell proliferation
reaction. A previous study showed that hMSCs could si-
lence T cells in the G0/G1 phase, which might be one of
the possible mechanisms for the hMSC inhibitory effect
on T cells [40]. We have assessed the hC-MSC immuno-
suppressive behavior by analyzing their ability to reduce
proliferation of PHA-stimulated PBMCs. As reported
by the PBMC cell cycle phase distribution, hC-MSCs
exerted an inhibitory effect on activated PBMC prolifera-
tion, by reducing significantly PBMCs in the S and
G2/M phases and blocking cells in the G0/G1 phase. Fur-
ther investigation may confirm perspective applications
in allogeneic conflicts.
Conclusion
A cadaveric cell population with morphological, pheno-
typic and functional properties typical of mesenchymal
stromal/stem cells survives in the vascular tissues after
4 days postmortem and following liquid nitrogen storage
for more than 5 years. The isolated hC-MSCs are
long lived in culture, highly proliferative and multipotent
for their strong ability to differentiate in different
mesengenic lineages; again these cells showed colony-
forming ability, capability to form embryo-like bodies
when grown in suspension and high immunosuppres-
sive properties. Based on these results, in addition to
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dant stem cell number, the procurement of hC-MSCs
from cadaveric vascular tissues may be an alternative and
inexhaustible reservoir of hMSCs for regenerative medi-
cine and transplantation procedures.
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